Moderna (MRNA) revenue was $1.9B in FY2025 (-40% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$1.9B
-40%
2024
$3.2B
-53%
2023
$6.8B
-64%
2022
$19.3B
+4%
2021
$18.5B
+2200%
2020
$803M
+1238%
2019
$60M
-56%
2018
$135M
-34%
2017
$206M
+90%
2016
$108M
Recent Quarterly Revenue
Quarter
Revenue
Q2 2026
$145M
Q1 2026
$389M
Q4 2025
$678M
Q3 2025
$1.0B
Q2 2025
$142M
Q1 2025
$108M
Q4 2024
$966M
Q3 2024
$1.9B
Q2 2024
$241M
Q1 2024
$167M
Q4 2023
$2.8B
Q3 2023
$1.8B
Source: MRNA on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.